
|
 |
Dispatch
Community-acquired Methicillin-resistant
Staphylococcus aureus, Uruguay
Xiao Xue Ma,* Antonio Galiana,† Walter Pedreira,†‡ Martin Mowszowicz,§
Inés Christophersen,† Silvia Machiavello,† Liliana Lope,† Sara Benaderet,‡
Fernanda Buela,‡ Walter Vicentino,‡ María Albini,¶ Olivier Bertaux,† Irene
Constenla,† Homero Bagnulo,† Luis Llosa,§ Teruyo Ito,* and Keiichi Hiramatsu*
*Juntendo University, Tokyo, Japan; †Hospital Maciel, Montevideo, Uruguay;
‡Centro de Asistencia del Sindicato Médico del Uruguay, Montevideo, Uruguay;
§Ministerio del Interior, Montevideo, Uruguay; and ¶Ministry of Public
Health, Montevideo, Uruguay
|
Appendix Table. Characteristics of 51 MRSA
strains isolated in the study period and 17 MRSA strains isolated
in prisons*
|
|
|
Pulsotype
|
SCCmec type†
|
No. of isolates
|
Coagulase-isotype‡
|
Exotoxine genes§
|
Clinical category¶
|
|
|
PVL
|
CNA
|
SEH
|
TSST1
|
bac
|
|
|
MRSA strain isolated from patients
|
|
A1
|
IVc
|
28
|
4
|
+
|
+
|
–
|
–
|
–
|
C-abscess(A-3[died, 1#], P-1), C-boils(A-5, P-1)
C-cellulitis (A-1, P-1#) H-cellulitis(A-2[1#]), H-wound infection(A-3)
C-hidradenitis (A-2) C-myositis (A-1) C-necro pneumo(A-2[died, 2#]),
H-VAP(A-2) H-bone joint (A-1[died, 1#]), C-sepsis (A- 3[died, 1#])
|
|
A1
|
IVc
|
1
|
4
|
+
|
–
|
–
|
–
|
–
|
C-wound infection (A-1)
|
|
A1
|
IVc
|
1
|
4
|
–
|
–
|
–
|
–
|
–
|
H-VAP(A-1)
|
|
A1
|
IVc
|
1
|
4
|
–
|
+
|
–
|
–
|
–
|
C-sepsis(A-1)#¶
|
|
A2
|
IVc
|
5
|
4
|
+
|
+
|
–
|
–
|
–
|
C-abscess (A-1, P-2) C-cellulitis (A- 1) C-bone
joint(A- 1)
|
|
A3
|
IVc
|
1
|
4
|
+
|
+
|
–
|
–
|
–
|
C- necro pneumo (A-1[died, 1] #)
|
|
A4
|
IVc
|
1
|
4
|
+
|
+
|
–
|
–
|
–
|
C-cellulitis (A-1)
|
|
B
|
V
|
1
|
7
|
–
|
+
|
–
|
+
|
–
|
H-atopic dermatitis (P-1)#¶
|
|
C1
|
IVa
|
2
|
2
|
–
|
–
|
–
|
-
|
–
|
H-catheter-associated infection(P-1)# H-cer spin
fluid shunt (P-1)
|
|
C2
|
IVc
|
1
|
2
|
–
|
–
|
–
|
+
|
–
|
C-wound infection(A-1)
|
|
C2
|
V
|
1
|
2
|
–
|
+
|
–
|
+
|
–
|
C-wound infection (A-1)
|
|
C3
|
II
|
2
|
2
|
–
|
–
|
–
|
–
|
–
|
H-VAP (A-1), U-sepsis syndrome (A-1)#¶
|
|
C4
|
IVa
|
1
|
2
|
–
|
–
|
–
|
+
|
–
|
U-sepsis syndrome (A-1)#
|
|
D
|
IVc
|
1
|
5
|
–
|
–
|
–
|
–
|
–
|
C-up resp tract (P-1)
|
|
E1
|
IVa
|
1
|
7
|
–
|
+
|
+
|
–
|
+
|
C-pneumonia (A-1)
|
|
E2
|
V
|
1
|
7
|
–
|
+
|
+
|
–
|
+
|
H-pneumonia (A-1)#
|
|
F
|
IVa
|
2
|
NT
|
–
|
–
|
–
|
–
|
–
|
H-respiratory tract colonization (A-2)
|
|
|
MRSA strains isolated from prison
|
|
A1
|
IVc
|
13
|
4
|
+
|
+
|
–
|
–
|
–
|
C-cellulitis (A-11), C-hidradenitis(A-2)
|
|
|
Reference strains
|
|
G
|
III
|
|
4
|
–
|
+
|
–
|
–
|
+
|
H-VAP(A-1)
|
|
(J4)
|
IVa
|
|
7
|
+
|
+
|
+
|
–
|
+
|
C-necro pneumo (died)
|
|
|
*MRSA, methicillin-resistant Staphylococcus aureus;
hidradenitis, hidradenitis suppurativa; necro pneumo, necrotizing
pneumonia; bone joint, bone and joint infection; VAP, ventilator-associated
pneumonia; up resp tract, upper respiratory tract infection.
|
|
†SCCmec type was determined by polymerase
chain reaction (PCR) amplification using the primer's sets described
previously (6–8). The primers used for
type IVc SCCmec element, 4c1 (5´-TCTATTCAATCGTTCTCGTATTT-3´)
and 4c2 (5´-TCGTTGTCATTTAATTCTGAACT-3´), were designed
based on the nucleotide sequence of type IVc SCCmec element
of strain 81/108, deposited in DDBJ/EMBL/GenBank databases accession
no. AB096217.
|
|
‡Coagulase isotyping: the type of coagulase was
determined by coagulation inhibition test using commercially available
neutralizing antisera specific to each of the 8 coagulase types
I to VIII, according to the method recommended by manufacturer (Denka
Seiken Co. Ltd, Niigata, Japan).
|
|
§Exotoxin genes were identified by PCR with sets
of primers as follows:PVL (Panton-Valentine leukocidin),
PVL-F (5´-ATGTCTGGACATGATCCAA-3´) and PVL-R
(5´-AACTATCTCTGCCATATGGT-3´); CNA (collagen-binding
protein), cna1 (5´-ACACCAGACGGTGCAACAATTA-3´)
and cna2 (5´-AGCAATACCGTTTGCATCTGTTA-3´); SEH
(staphylococcal enterotoxin H ), entH-F (5´-ATTCACATCATATGCGAAAGCAG-3´),
and entH-R (5´-ATGTCGAATGAGTAATCTCTAG-3´); TSST1
(toxic shock syndrome toxin-1), TSST1A (5´-TGATATGTGGATCCGTCAT-3´),
and TSST1B (5´-AAACACAGATGGCAGCAT-3´); bac
(bacteriocine gene found in MW2), epiA-F (5´-GACGAACGTATTACAAGTCATA-3´),
and epiB-R (5´-TAAGTACGCTGCTTCAGATATA-3´).
|
|
¶Clinical categories are based on Table 1. Those
of the strains not listed in Table 1 are in italic Onset: onset
of infection in either community(C), hospital (H), or unknown (U).
Numbers in parenthesis indicate the number of cases: A, adult cases;
P, pediatric cases. The number of cases in which patient died is
indicated in brackets.
|
|
#Patient had bacteremia.
|
|